Deadline: 6 September 2017
The European Commission is seeking applications for its initiative “The Birth Day Prize”. The Bill & Melinda Gates Foundation (or the Foundation) and Merck Sharp & Dohme Corp., subsidiary of Merck & Co. Inc., Kenilworth, NJ USA (or MSD) have committed to award prizes to winners following evaluation of entries by the Commission.
The Horizon Prize on reducing maternal and newborn morbidity and mortality – the Birth Day Prize – will be awarded to the contestants who demonstrate a novel solution to improve the outcome of facility-based deliveries, which might be of clinical, technological or managerial nature, or a combination of these. Any solution must take full account of relevant social factors and have the potential of scaling up rapidly.
The objective is a demonstrated reduction in maternal and/or newborn morbidity and mortality and/or stillbirth during facility-based deliveries.
- Reduce maternal and/or new-born deaths, stillbirths and/or maternal and new-born morbidity rates related to giving birth in facility-based deliveries
- Improve quality and outcomes of care surrounding facility-based delivery
- The European Commission will award a prize of 1 Million EUR.
- Additional Prizes:
- The Bill & Melinda Gates Foundation and Merck Sharp & Dohme Corp. have each committed to award the winning contestants selected by the European Commission.
- The additional funding envisaged by the Bill & Melinda Gates Foundation is 1 Million EUR.
- The additional funding envisaged by Merck Sharp & Dohme Corp. is 500 000 EUR.
- Up to 2 (two) additional prizes may be awarded.
- The contest is open to any legal entity (including natural persons) or groups of legal entities.
- Participants who have already been awarded an EU or Euratom prize cannot receive a second prize for the same activities.
How to Apply
Applications must be submitted online via given website.
For more information, please visit Birth Day Prize.